文献速递肾癌与肾肿瘤

肾部分切除术结局的变异性:外科医生因素重要吗?

Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter?
PubMed 文献 · Eur Urol · 2018-11-02

该回顾性研究纳入2011至2016年单中心19名外科医生完成的1461例肾部分切除术,采用分层回归模型分析患者与医生因素对围手术期及术后结局变异性的贡献。结果显示除肾功能结局外,多数关键结局存在显著的医生间变异,可量化的医生因素解释了术中结局10-40%及切缘与并发症90-100%的变异。

要点

  • 肾部分切除术后多数关键结局存在显著的外科医生间变异。
  • 肾功能结局在不同医生间保持一致,无显著差异。
  • 可量化与不可量化的医生因素共同解释剩余结局18-100%的变异。

核心结论

  • 即使校正患者特征后,肾部分切除术后的多个关键结局仍存在显著的医生间变异。
  • 肾脏功能结局在不同医生间表现一致,但其余围手术期和术后变量的变异中18-100%可归因于可测量和不可测量的医生因素。

研究设计与样本

  • 回顾性综述,纳入2011至2016年单中心19名外科医生完成的1461例肾部分切除术患者。
  • 采用分层线性与逻辑回归模型,分析固定患者与医生因素对结局变异性的贡献百分比。

主要发现

  • 零模型下,手术时间、估计失血量、缺血时间、切除体积损失、住院天数、切缘阳性、Clavien并发症和30天再入院率均存在显著医生间变异(均p<0.001)。
  • 慢性肾脏病分期升级(p=0.47)和肾小球滤过率保留百分比(p=0.49)无显著医生间变异。
  • 患者因素解释了切除体积损失变异的82%,其余结局的0-32%。
  • 可量化医生因素解释术中结局变异的10-40%,切缘率和患者并发症结局变异的90-100%。
  • 不可测量医生因素解释了手术时间(27%)、估计失血量(6%)和缺血时间(31%)的残余变异。

临床怎么用

  • 临床应关注肾部分切除术中医生因素对手术时间、失血量、切缘状态和并发症等结局的影响。
  • 在价值医疗背景下,需识别并优化可改变的医生因素以改善患者结局。

局限性

  • 单中心回顾性研究,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding physician-level discrepancies is increasingly a target of US healthcare reform for the delivery of quality-focused patient care. OBJECTIVE: To estimate the relative contributions of patient and surgeon characteristics to the variability in key outcomes after partial nephrectomy (PN). DESIGN, SETTING, AND PARTICIPANTS: Retrospective review of 1461 patients undergoing PN performed by 19 surgeons between 2011 and 2016 at a tertiary care referral center. INTERVENTION: PN for a renal mass. OUTCOMES MEASUREMENTS AND STATISTICAL ANALYSIS: Hierarchical linear and logistic regression models were built to determine the percentage variability contributed by fixed patient and surgeon factors on peri- and postoperative outcomes. Residual between- and within-surgeon variability was calculated while adjusting for fixed factors. RESULTS AND LIMITATIONS: On null hierarchical models, there was significant between-surgeon variability in operative time, estimated blood loss (EBL), ischemia time, excisional volume loss, length of stay, positive margins, Clavien complications, and 30-d readmission rate (all p<0.001), but not chronic kidney disease upstaging (p=0.47) or percentage preservation of glomerular filtration rate (p=0.49). Patient factors explained 82% of the variability in excisional volume loss and 0-32% of the variability in the remainder of outcomes. Quantifiable surgeon factors explained modest amounts (10-40%) of variability in intraoperative outcomes, and noteworthy amounts of variability (90-100%) in margin rates and patient morbidity outcomes. Immeasurable surgeon factors explained the residual variability in operative time (27%), EBL (6%), and ischemia time (31%). CONCLUSIONS: There is significant between-surgeon variability in outcomes after PN, even after adjusting for patient characteristics. While renal functional outcomes are consistent across surgeons, measured and unmeasured surgeon factors account for 18-100% of variability of the remaining peri- and postoperative variables. With the increasing utilization of value-based medicine, this has important implications for the goal of optimizing patient care. PATIENT SUMMARY: We reviewed our institutional database on partial nephrectomy performed for renal cancer. We found significant variability between surgeons for key outcomes after the intervention, even after adjusting for patient characteristics.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Dagenais J, Bertolo R, Garisto J, et al. Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter? Eur Urol. 2018. PMID: 30396636. doi:10.1016/j.eururo.2018.10.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。